Henry Schein Community

NasdaqGS:HSIC Community

1 Narratives written by author
0 Comments on narratives written by author
6 Fair Values set on narratives written by author

AN

AnalystConsensusTarget

Consensus Narrative from 14 Analysts

Expansion In BioHorizons And Acentus Will Drive Future Success

Key Takeaways High-growth and high-margin businesses, along with own brand products, are set to enhance revenue growth and net margins significantly in the coming years. Strategic acquisitions, product line expansions, and technological shifts are expected to drive incremental sales and boost profitability.

US$77.96

FV

15.0% undervalued

3.39%

Revenue growth p.a.

0

0

4

1 day ago